Ultrasound, Nutritional Status, and Outcomes in Surgical ICU
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorOsijek University Hospital
About this trial
Ultrasound Indicators of Nutritional Status and Treatment Outcomes in Surgical Patients in the Intensive Care Unit
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
postoperative intensive care
Disqualifiers
surgery of the right leg
paraplegia, tetraplegia
refusal of the patient/guardian to participate in the research (informed consent not signed)
Trial population
The study population will be randomly selected patients admitted to the intensive care unit after undergoing a surgical procedure. These surgical procedures include abdominal, neurosurgical, plastic-reconstructive, traumatological, thoracic, and maxillofacial surgeries. Patients will be included regardless of age, gender, or whether the procedure was emergency or elective.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
50 Participants
are grouped into 1 trial groupGroup A: Surgical patients in the intensive care unit
Trial outcomes
Primary outcomes
1
Clinical Frailty Scale
The Clinical Frailty Scale (CFS) is a 9-point clinician-judgment tool that assesses fitness-to-frailty (1=Very Fit, 9=Terminally Ill).
Time frame
Day 1 (within 24 hours from admission to the intensive care unit)2
Nutritional Risk Screening 2002
The Nutritional Risk Screening 2002 (NRS-2002) is a rapid, validated tool designed by the European Society for Clinical Nutrition and Metabolism (ESPEN) to identify hospitalized patients at risk of malnutrition and requiring nutritional support. It calculates a total score (0-7) based on impaired nutritional status, disease severity, and age (≥70 years).
Time frame
Day 13
Vastus intermedius thickness
Vastus intermedius thickness measured by ultrasound and expressed in centimeters.
Time frame
Day 14
Rectus femoris thickness
Rectus femoris thickness measured by ultrasound and expressed in centimeters.
Time frame
Day 1Secondary outcomes
1
Haemoglobin
Haemoglobin levels (g/L) will be measured in the blood sample.
Time frame
Day 12
Albumin
The albumin level (g/L) will be measured in the blood sample.
Time frame
Day 13
C-reactive protein (CRP)
C-reactive protein (CRP) is a liver-produced protein that serves as a key biomarker of systemic inflammation, infection, and tissue damage. CRP (mg/L) will be measured in the blood sample.
Time frame
Perioperative4
Lactate
Lactate (mmol/L) is an energy source and a metabolic product produced in muscles, red blood cells, and the brain during anaerobic metabolism. It serves as a marker of tissue oxygenation, with elevated blood levels suggesting potential metabolic stress.
Time frame
Day 1Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov